Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OZY | Ann: OZY NTA 17-04-2024 $4.66468 | 08:08 | 0 | 13 | |||
|
|||||||
OZY | Ann: OZY NTA 16-04-2024 $4.69611 | 17/04/24 | 0 | 21 | |||
|
|||||||
OZY | Ann: OZY NTA 15-04-2024 $4.77410 | 16/04/24 | 0 | 28 | |||
|
|||||||
OZY | Ann: OZY NTA 12-04-2024 $4.79244 | 15/04/24 | 0 | 30 | |||
|
|||||||
OZY | Ann: OZY NTA 11-04-2024 $4.80834 | 12/04/24 | 0 | 41 | |||
|
|||||||
OZY | Ann: OZY NTA 10-04-2024 $4.84157 | 11/04/24 | 0 | 33 | |||
|
|||||||
OZY | Ann: OZY NTA 09-04-2024 $4.82927 | 10/04/24 | 0 | 31 | |||
|
|||||||
OZY | Ann: OZY NTA 08-04-2024 $4.79522 | 09/04/24 | 0 | 29 | |||
|
See All Discussions